文献速递垂体与肾上腺疾病

GnRH/LH反应性原发性醛固酮增多症的遗传学特征

Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

研究对50例确诊原发性醛固酮增多症(PA)患者进行GnRH/LH反应性体内评估及CTNNB1、KCNJ5等基因分析;23例体内测试者中7例(30.4%)对GnRH呈阳性反应、4例(17.4%)部分反应、12例(52.2%)无反应;未发现体细胞CTNNB1突变,但部分病例携带KCNJ5、CACNA1D或ATP1A1突变。

要点

  • 23例体内测试GnRH反应者中7例(30.4%)阳性、4例(17.4%)部分反应、12例(52.2%)无反应。
  • 未检出体细胞CTNNB1突变;部分GnRH/LH反应病例携带KCNJ5致病突变。
  • 未行GnRH测试的26例中检出CTNNB1 2例(7.7%)、KCNJ5 13例(50%)、CACNA1D 1例(3.8%)。

核心结论

  • PA中GnRH对醛固酮的异常调节较常见,但多不与体细胞CTNNB1突变相关,可见于体细胞KCNJ5突变。

研究设计与样本

  • 对确诊PA患者进行GnRH/LH调节醛固酮的体内评估,并对本队列及未行GnRH反应测试的对照PA队列行CTNNB1、KCNJ5、ATP1A1、ATP2B3、CACNA1D、GNAS基因分析。
  • 共研究50例确诊PA患者,包括36例醛固酮 producing 腺瘤(APA)、12例双侧大结节性肾上腺增生、1例嗜酸细胞瘤、1例伴皮质醇共分泌的双侧增生。

主要发现

  • 23例体内测试GnRH反应者中7例(30.4%)阳性、4例(17.4%)部分反应、12例(52.2%)无反应。
  • 未发现体细胞CTNNB1突变;致病性c.451G>C KCNJ5突变见于2例(分别呈部分和无GnRH反应)及1例对LH呈阳性反应者。
  • 另发现体细胞致病突变CACNA1D c.776T>A和ATP1A1 c.311T>G各1例,均见于无GnRH反应者。
  • 未行GnRH反应测试的26例中检出CTNNB1 2例(7.7%)、KCNJ5 13例(50%)、CACNA1D 1例(3.8%)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recently, somatic β-catenin mutations (CTNNB1) identified in aldosterone-producing adenomas (APAs) from three women were suggested to be responsible for the aberrant overexpression of luteinizing hormone/choriogonadotropin receptor and gonadotropin-releasing hormone receptor in the APA. OBJECTIVE: To genetically characterize patients with primary aldosteronism (PA) evaluated in vivo for gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH)-responsive aldosterone secretion. METHOD: Patients with PA were evaluated in vivo to determine the possible regulation of aldosterone secretion by GnRH or LH. Genetic analysis of the CTNNB1, KCNJ5, ATP1A1, ATP2B3, CACNA1D, and GNAS genes were performed in this cohort and a control cohort of PA not tested in vivo for GnRH response. RESULTS: We studied 50 patients with confirmed PA, including 36 APAs, 12 bilateral macronodular adrenal hyperplasias, 1 oncocytoma, and 1 bilateral hyperplasia with cosecretion of cortisol. Among 23 patients tested in vivo for GnRH response of aldosterone, 7 (30.4%) had a positive response, 4 (17.4%) a partial response, and 12 (52.2%) no response. No somatic CTNNB1 mutations were identified, but the disease-causing c.451G>C KCNJ5 mutation was found in two individuals with partial and no GnRH responses and an individual showing a positive response to LH. Two additional somatic pathogenic mutations, CACNA1D c.776T>A and ATP1A1 c.311T>G, were identified in two patients with no GnRH responses. In the 26 patients not tested for GnRH response, we identified 2 CTNNB1 (7.7%), 13 KCNJ5 (50%), and 1 CACNA1D (3.8%) mutations. CONCLUSION: Aberrant regulation of aldosterone by GnRH is frequent in PA, but is not often associated with somatic CTNNB1, although it may be found with somatic KCNJ5 mutations.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Gagnon N, Cáceres-Gorriti KY, Corbeil G, et al. Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism. J Clin Endocrinol Metab. 2018. PMID: 29726953. doi:10.1210/jc.2018-00087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。